Alison Early, MD
Ophthalmology · Blue Ash, OHNPI 1457771834
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $50,508 of the $69,230 with a category attached, or 73.0%. 32 manufacturers reported payments, led by Rxsight Inc at 31.4% of the total. 2025 is the largest year on record at $40,644, more than ten times the $602 reported in 2019. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $329.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$22K
- Alcon$11K
- Bausch & Lomb Americas Inc.$11K
- Beaver-visitec International, Inc.$7K
- Tarsus Pharmaceuticals, Inc.$5K
- Harrow Eye, LLC$3K
- plus $11K from 26 others
Across 2 payments — averaging $2227.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$4K
What the payments were for
- Consulting fees$50,50873%
- Speaking & faculty fees$7,20010%
- Travel & lodging$3,9016%
- Food & beverage$7,51111%
- Education$890%
- Gifts$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 10 | $21,728 |
| Alcon | 46 | $10,935 |
| Bausch & Lomb Americas Inc. | 20 | $10,536 |
| Beaver-visitec International, Inc. | 2 | $6,600 |
| Tarsus Pharmaceuticals, Inc. | 25 | $5,491 |
| Harrow Eye, LLC | 3 | $3,018 |
| Johnson & Johnson Surgical Vision, Inc. | 10 | $2,654 |
| Lensar, Inc. | 3 | $1,745 |
| Carl Zeiss Meditec USA, Inc. | 10 | $1,735 |
| Ocular Therapeutix, Inc. | 8 | $1,722 |
| AbbVie(2 entities) | 24 | $715 |
| Nordic Pharma, Inc. | 1 | $480 |
| Carl Zeiss Meditec, Inc. | 3 | $325 |
| Glaukos Corporation | 2 | $238 |
| Ivantis, Inc | 3 | $223 |
| Sight Sciences, Inc. | 3 | $204 |
| Novartis | 8 | $140 |
| Biotissue Holdings Inc. | 6 | $133 |
| Thea Pharma Inc. | 1 | $115 |
| Rayner Intraocular Lenses Limited | 2 | $71 |
| Kala Pharmaceuticals, Inc. | 3 | $64 |
| Astellas Pharma US Inc | 2 | $47 |
| Aerie Pharmaceuticals, Inc. | 3 | $45 |
| Dompe US, Inc. | 2 | $38 |
| Alimera Sciences, Inc. | 2 | $38 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $38 |
| Amgen | 1 | $37 |
| Lombart Brothers, Inc. | 1 | $30 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Haag-streit USA, Inc. | 1 | $21 |
| Tearlab Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$21,510
- RXSIGHT INJECTOR CARTRIDGE$21,510
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$21,510
- LIGHT ADJUSTABLE LENS (LAL)$21,510
- RXSIGHT INJECTOR HANDPIECE$21,510
- Centurion$7,150
- IHEEZO$2,975
- Tecnis Simplicity$2,400
- Tecnis IOL$2,255
- LENSAR LASER SYSTEM$1,648
- XDEMVY$1,320
- Lacrifill$480
- Clareon$172
- VisuMax$156
- VYZULTA$143
- iDoseTR$141
- LUMIGAN$136
- NGENUITY$126
- VERACITY SURGICAL$125
- DEXTENZA$121
How this compares
$69,230 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 16 | $30,288 |
| RestasisCyclosporine | 27 | $27,829 |
| Cyclosporine | 16 | $12,395 |
| Prednisolone Acetate | 269 | $10,851 |
| Ketorolac Tromethamine | 255 | $7,170 |
| Loteprednol Etabonate | 20 | $2,597 |
| Latanoprost | 140 | $1,050 |
| ValacyclovirValacyclovir Hcl | 13 | $635 |
| Timolol Maleate | 70 | $574 |
| Brimonidine Tartrate | 12 | $490 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 43 | $272 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $5,491 | $30,28816 claims |
| AbbVieRestasis | $715 | $27,82927 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $38 | $2,59720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 640 ophthalmology providers in Ohio.
Other ophthalmology in Blue Ash
- Lucas LindsellBlue Ash$142K
- Arjun SoodBlue Ash$99K
- James OsherBlue Ash$11K
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.